Cases started on MDR-TB treatment in Norway

Norway: Cases started on MDR-TB treatment was 15 in 2024. ◆ Volatile

Latest (2024)
15
Change on year
down 6.2%
World rank
110th
of 193 countries
All-time high
209
in 2018
All-time low
2
in 2019
Years of data
13
2010–2024

Cases started on MDR-TB treatment in Norway, 2010–2024

0501001502002010201720242010: 82011: 42012: 62013: 62015: 52016: 112018: 2092019: 22020: 22021: 102022: 112023: 162024: 15

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for cases started on mdr-tb treatment in Norway is 15, measured in 2024.

That represents a change of down 6.2% on the previous year and up 150.0% over ten years.

Over the whole period, cases started on mdr-tb treatment in Norway peaked at 209 in 2018 and was at its lowest, 2, in 2019.

Norway ranks 110th of 193 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Averages by decade

DecadeAverage LowestHighest Years
2010s 31.38 2 209 8
2020s 10.8 2 16 5

Countries ranked near Norway

  1. 108 Hungary 18 compare
  2. 109 Canada 16 compare
  3. 110 Honduras 15 compare
  4. 112 Czechia 14 compare
  5. 113 Estonia 13 compare
  6. 113 Netherlands 13 compare
  7. 113 Libya 13 compare

See the full ranking of 205 places →

More health data for Norway

All data for Norway →

Frequently asked questions

What is cases started on mdr-tb treatment in Norway?
Cases started on mdr-tb treatment in Norway was 15 in 2024, according to World Health Organization, Global Health Observatory.
What is the highest cases started on mdr-tb treatment recorded in Norway?
The highest recorded value was 209 in 2018.
What is the lowest cases started on mdr-tb treatment recorded in Norway?
The lowest recorded value was 2 in 2019.
How does Norway rank for cases started on mdr-tb treatment?
Norway ranks 110th out of 193 countries with data for 2024.
Is cases started on mdr-tb treatment rising or falling in Norway?
Over the last ten years it is up 150.0%. The long-run trend across the full record is volatile.
Where does this Norway data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 13 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

About this data

Indicator
Cases started on MDR-TB treatment
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,209 data points, 2005–2024
Last refreshed